Antimicrobial Effects of Equine Platelet Lysate.
Authors: Gordon Julie, Álvarez-Narváez Sonsiray, Peroni John F
Journal: Frontiers in veterinary science
Summary
# Antimicrobial Effects of Equine Platelet Lysate Antimicrobial resistance presents an increasingly urgent challenge in equine medicine, prompting investigation into alternative strategies beyond conventional antibiotics. Gordon and colleagues examined whether platelet lysate (PL)—an acellular, growth-factor-rich product manufactured via plateletpheresis from pooled equine donors—possesses antimicrobial properties against clinically relevant bacterial pathogens. Their in vitro work across gram-positive (*Staphylococcus aureus*, *Enterococcus faecalis*) and gram-negative (*Escherichia coli*, *Pseudomonas aeruginosa*) bacteria revealed that PL not only suppressed bacterial growth compared to standard culture media, but also reduced growth rates and maximum yield across all strains tested. Notably, the mechanism differed by species: *E. coli* and *P. aeruginosa* demonstrated concentration-dependent inhibition with delayed exponential growth phases, whilst *S. aureus* and *E. faecalis* showed inhibition independent of PL concentration—a distinction with important implications for clinical dosing protocols. For practitioners managing contaminated or infected wounds, this work suggests platelet lysate warrants further investigation as a biologically-derived antimicrobial option, particularly valuable in cases where antibiotic resistance or limited systemic antibiotic options constrain conventional treatment.
Read the full abstract on PubMed
Practical Takeaways
- •Equine platelet lysate shows promise as a biological antimicrobial agent, though clinical application requires further in vivo validation before practical implementation
- •Different bacterial species respond differently to platelet lysate, suggesting dosing and clinical protocols would need to be tailored by organism type
- •This research provides foundational evidence for developing alternatives to conventional antibiotics in equine medicine, addressing growing antimicrobial resistance concerns
Key Findings
- •Platelet lysate (PL) significantly reduced bacterial content compared to normal growth media across multiple gram-positive and gram-negative strains
- •E. coli and P. aeruginosa growth was reduced in a concentration-dependent manner, while S. aureus and E. faecalis showed non-concentration-dependent effects
- •PL delayed the onset of exponential growth for E. coli and P. aeruginosa, with implications for clinical dosing schedules
- •Platelet lysate demonstrated broad-spectrum antimicrobial properties as a potential alternative to traditional antibiotics